The suppressive effect of the three-herb extract mixture on vascular and liver inflammation in atherogenic diet with high fructose-fed mice

Pharm Biol. 2018 Dec;56(1):32-42. doi: 10.1080/13880209.2017.1412468.

Abstract

Context: Cynanchum wilfordii (Maximowicz) Hemsley (Apocynaceae), Arctium lappa L. var. rubescens Frivald (Asteraceae) and Dioscorea opposite Thunb (Dioscoreaceae) root extracts have been widely used as an alternative for intervening obesity.

Objectives: The synergistic effect of three-herb mixture of C. wilfordii, A. lappa and D. opposita was determined on aortic and liver inflammatory responses.

Materials and methods: CWE, ALE and DOE were prepared from the root of C. wilfordii, A. lappa and D. opposite by 70% ethanol extraction, respectively. CADE was prepared using a powder mixture of 2 CWE:1 ALE:1 DOE. C57BL/6 mice were fed an atherogenic diet combined with 10% fructose (ATHFR) in the presence of 200 mg/kg/day CWE, ALE, DOE or CADE for 8 weeks (each group, n = 6). Biochemical profiles, protein expression of vascular cell adhesion molecule-1 (VCAM-1) on the aorta and liver were determined.

Results: CADE could significantly suppress the protein expression of VCAM-1 in both the aorta and liver (80% reduction) compared to ATHFR-fed mice. Impairment of liver function was significantly ameliorated by CADE supplement, as determined by GOT (60% reduction) and GPT (51% reduction) levels.

Conclusions: CADE should be considered when developing medications to suppress the vascular and liver inflammatory responses for individuals who are either non-responsive or resistant to lipid-lowering drugs.

Keywords: Inflammation; P-selectin; fat accumulation; lipid-lowering; obesity; synergistic effect; vascular cell adhesion molecule-1.

MeSH terms

  • 3T3 Cells
  • Animals
  • Aorta / drug effects*
  • Aorta / metabolism
  • Aorta / pathology
  • Arteritis / drug therapy*
  • Arteritis / metabolism
  • Arteritis / pathology
  • Cells, Cultured
  • Diet, Atherogenic / adverse effects*
  • Fructose / administration & dosage
  • Fructose / toxicity*
  • Hepatitis / drug therapy*
  • Hepatitis / metabolism
  • Hepatitis / pathology
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / metabolism
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Plant Roots
  • Random Allocation
  • Treatment Outcome

Substances

  • Plant Extracts
  • Fructose

Grants and funding

This work was supported by National Academy of Agricultural Science of Rural Development Administration, Republic of Korea [PJ01130412].